Schizophrenia Clinical Trials in Las Vegas
View 11 new treatments for Schizophrenia in Las Vegas, NV, and nearby areas, such as Henderson. Every day, Power helps hundreds of schiz patients connect with leading medical research.Filter Results
Condition
All
How old are you?
Trial Phase
All
Trial Status
All
KarXT for Schizophrenia
Karuna Clinic, Las Vegas + 1 more
This trial tests KarXT, a combination of two drugs, for people who haven't improved with their current treatment. KarXT aims to balance brain functions and reduce side effects. The study will look at improvements in health and daily life. KarXT has shown positive results in earlier tests.Show More
Recruiting
Phase 3
Est. 5 - 8 Weeks
Ronald Marcus, MD
Study Director
KarXT for Schizophrenia
Karuna Clinic, Las Vegas + 4 more
This trial tests the safety and tolerability of KarXT, a combination of two drugs, in schizophrenia patients who haven't responded well to their current treatments. KarXT aims to improve symptoms and manage side effects better than existing medications. KarXT (xanomeline plus trospium) is an emerging treatment for schizophrenia, showing promise in managing total, positive, and negative symptoms.Show More
Recruiting
No Placebo Trial
Phase 3
Est. 3 - 6 Weeks
Bristol-Myers Squibb
Study Director
Dexmedetomidine for Agitation in Schizophrenia and Bipolar Disorder
BioXcel Clinic, Las Vegas + 1 more
In this study, an investigational medication named BXCL501 is being tested for the treatment of episodes of agitation associated with bipolar I and bipolar II disorder, schizophrenia, schizoaffective and schizophreniform disorder. This study compares the study drug to a placebo.Show More
Waitlist
Phase 3
Est. 6 - 12 Weeks
Robert Risinger, MD
Study Chair
Valbenazine for Schizophrenia
Neurocrine Clinic, Las Vegas + 1 more
The primary objective for this study is to evaluate the effect of adjunctive valbenazine versus placebo on symptoms of schizophrenia in participants who have inadequate response to antipsychotic treatment.Show More
Recruiting
Phase 3
Est. 5 - 8 Weeks
Clinical Development Lead
Study Director
Iclepertin for Schizophrenia
Boehringer Ingelheim Clinic, Las Vegas + 1 more
This trial tests if a daily pill called Iclepertin can improve learning and memory in adults with schizophrenia. Participants take either Iclepertin or another pill for several months while continuing their usual medication. Doctors regularly check their mental abilities and overall health.Show More
Recruiting
Phase 3
Est. 4 - 6 Weeks
Unregistered Study Lead
Research Team
MK-8189 for Schizophrenia
Merck Sharp & Dohme Clinic, Las Vegas + 1 more
This trial tests the effectiveness and safety of a medication called MK-8189 in adults with acute schizophrenia. The study compares different doses of the medication to see if it can better reduce symptoms. The goal is to find out if MK-8189 can help improve the condition of these patients.Show More
Recruiting
Phase 2
Est. 3 - 6 Weeks
Medical Director
Study Director
Emraclidine for Schizophrenia
Cerevel Clinic, Las Vegas + 1 more
This trial aims to evaluate the safety and tolerability of a medication called emraclidine, taken by mouth, in adults with schizophrenia.
Recruiting
No Placebo Trial
Phase 2
Est. 6 - 12 Weeks
Erica Koenig, PhD
Study Director
Page 1 of 1
Frequently Asked Questions
Explore related conditions